Profil
Sean McAuliffe is currently the Chief Business Officer at Taysha Gene Therapies, Inc. Prior to his current position, he served as the Vice President-Marketing at Novartis Gene Therapies, Inc. from 2018 to 2020.
Aktive Positionen von Sean McAuliffe
Unternehmen | Position | Beginn |
---|---|---|
TAYSHA GENE THERAPIES, INC. | Corporate Officer/Principal | 01.06.2020 |
Ehemalige bekannte Positionen von Sean McAuliffe
Unternehmen | Position | Ende |
---|---|---|
AVEXIS INC | Sales & Marketing | 01.06.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TAYSHA GENE THERAPIES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |